Stocks in News: સુઝલોન, આસ્ક ઓટોમોટિવ, ટાટા ટેકનોલોજિસ, One 97 Communications
Tata Technologies Limited IPO
Date : | 22-Nov to 24-Nov-2023 |
FV : | ₹2 |
Price : | ₹475 – ₹500 |
Market Lot : | 30 Shares |
App Amt : | ₹15,000 |
Size : | ₹3,042.51 Cr |
EMP : | 101.42 Cr |
Retail Form : | 615,264 |
HNI Small Form : | 6,278 |
HNI Big Form : | 12,556 |
QIB : | 50% |
NII : | 15% |
Retail : | 35% |
Listing At : | BSE, NSE |
Registrar : | Link Intime |
અમદાવાદ, 16 નવેમ્બરઃ માર્કેટમાં નવા વર્ષની શરૂઆતમાં બે કંપનીઓ ચર્ચામાં છે. એક તો ટાટા મોટર્સની ટાટા ટેકનોલોજીસનો આઇપીઓ અને બીજી સુઝલોન. તે ઉપરાંત ઓએજીસી પણ રૂ. 1 લાખ કરોડ એકત્ર કરવાની યોજના ધરાવે છે. ટીસીએસએ પણ તેની રૂ. 17000 કરોડની બાયબેક ઓફરમાં 4.09 કરોડ શેર્સની બાયબેક ઓફર માટેની રેકોર્ડ તારીખ 25 નવેમ્બર જાહેર કરી છે.
ASK Automotive: Goldman Sachs Funds Goldman Sachs India Equity Portfolio has bought 23.2 lakh equity shares (Positive)
Suzlon: Company’s S144, 3 MW ‐ 3.15 MW wind turbine series gets the RLMM Listing from Ministry of New and Renewable Energy (Positive)
Tata Motors: Tata Technologies IPO opens for subscription on November 22 (Positive)
One 97 Communications: Company has announced a partnership with global travel technology company Amadeus to redefine travel experience with Artificial Intelligence. (Positive)
VST Tillers: Unveils 3 brand new tractors, including its indigenously developed electric tractor, at the Agritechnica 2023 at Hanover in Germany (Positive)
Securities In F&O Ban For 16-Nov-2023
DELTACORP | HINDCOPPER |
IBULHSGFIN | MCX |
SAIL | ZEEL |
Dabur: Two Foreign Subsidiaries Dabur International and Dermoviva Skin Essentials have been dismissed as defendants in federal cases before the US Court (Positive)
ONGC: Company plans to invest about ₹1 lakh crore in setting up two petrochemical plants to convert crude oil directly into high-value chemical products (Positive)
Cipla: Company has completed the sale of a 51.18 per cent stake in Uganda-based Cipla Quality Chemical Industries Ltd (Positive)
TCS Buyback Record Date Announced 👍
Buyback Price : | 4,150 ₹ |
Last Closing Price : | 3,404 ₹ |
Buyback Size ₹ : | 17,000 Crore |
Buyback Size: | 4,09,63,855 Shares |
Retail Quota : | 61,44,579 Shares |
Record Date : | Saturday, 25th November |
Gland Pharma: Company has received approval from the US health regulator to market a generic product used to raise blood pressure. (Positive)
Ramkrishna Forgings: Company announced that it has raised ₹1,000 crore through a qualified institutional placement (Neutral)
Jyoti Structures: Board meet today to Consider Fund Raising Via Issue Of Shares/ Convertible Bonds/ Debentures, etc (Neutral)
DCX Systems: Board meet today to Consider Fund Raising via Issue of Shares or Convertible Instruments (Neutral)
Bayer Cropscience: Company will trade ex-dividend with effect from November 16. The interim dividend is Rs 105 per share. (Neutral)
Satin Creditcare: Company said the board members will meet on November 20 to consider the fund raising (Neutral)
TCS: Company sets November 25 as record date for ₹17,000 crore share buyback (Neutral)
Bank Of Baroda: Meeting of Capital Raising Committee on Nov 18 (Neutral)
IIFL Finance: Company to invest up to Rs 200 crore in arm IIFL Samasta Finance via share purchase (Neutral)
TCS: Employees Union NITES accuses TCS of “unethical transfer practices” for employees, weeks after end of work of home. (Neutral)
Vedanta: Company sets up copper business subsidiary in Saudi Arabia for SAR 1 lakh (Neutral)
Brightcom: Company approves appointment of Brand & Associates as new statutory auditors effective November 15. (Neutral)
Bajaj Finance: RBI directs to stop sanction and disbursal of loans under eCOM and Insta EMI Card. (Negative)
Rategain: Company launches QIP of Size Rs 600 cr. Indicative issue price of Rs 643 per share is at discount of 9.68% to last closing price (Negative)
બિઝનેસ ગુજરાત વેબસાઈટમાં આવતાં news updates મેળવવા માટે નીચેની લિંક ઉપર ક્લિક કરી ફોલો કરો
https://whatsapp.com/channel/0029VaDvQgaDOQIYqUTAu20r
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)